These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1113 related articles for article (PubMed ID: 17379095)
21. Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. Jacobi A; Thieme S; Lehmann R; Ugarte F; Malech HL; Koch S; Thiede C; Müller K; Bornhäuser M; Ryser M; Brenner S Exp Hematol; 2010 Mar; 38(3):180-90. PubMed ID: 20035824 [TBL] [Abstract][Full Text] [Related]
22. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Yoshimoto G; Miyamoto T; Jabbarzadeh-Tabrizi S; Iino T; Rocnik JL; Kikushige Y; Mori Y; Shima T; Iwasaki H; Takenaka K; Nagafuji K; Mizuno S; Niiro H; Gilliland GD; Akashi K Blood; 2009 Dec; 114(24):5034-43. PubMed ID: 19808698 [TBL] [Abstract][Full Text] [Related]
23. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells. Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217 [TBL] [Abstract][Full Text] [Related]
24. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785 [TBL] [Abstract][Full Text] [Related]
25. Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells. Ferrell CM; Dorsam ST; Ohta H; Humphries RK; Derynck MK; Haqq C; Largman C; Lawrence HJ Stem Cells; 2005 May; 23(5):644-55. PubMed ID: 15849172 [TBL] [Abstract][Full Text] [Related]
26. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343 [TBL] [Abstract][Full Text] [Related]
27. FLT3/ ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signalling. Katsumi A; Kiyoi H; Abe A; Tanizaki R; Iwasaki T; Kobayashi M; Matsushita T; Kaibuchi K; Senga T; Kojima T; Kohno T; Hamaguchi M; Naoe T Eur J Haematol; 2011 Mar; 86(3):191-8. PubMed ID: 21114537 [TBL] [Abstract][Full Text] [Related]
28. Constitutively activated FLT3 phosphorylates BAD partially through pim-1. Kim KT; Levis M; Small D Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825 [TBL] [Abstract][Full Text] [Related]
29. The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. Manfredini R; Zini R; Salati S; Siena M; Tenedini E; Tagliafico E; Montanari M; Zanocco-Marani T; Gemelli C; Vignudelli T; Grande A; Fogli M; Rossi L; Fagioli ME; Catani L; Lemoli RM; Ferrari S Stem Cells; 2005 Apr; 23(4):496-506. PubMed ID: 15790771 [TBL] [Abstract][Full Text] [Related]
30. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795 [TBL] [Abstract][Full Text] [Related]